Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.76)
# 660
Out of 5,180 analysts
96
Total ratings
42.42%
Success rate
11.11%
Average return
Main Sectors:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PLRX Pliant Therapeutics | Maintains: Overweight | $4 → $3 | $1.19 | +152.10% | 3 | Mar 12, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Overweight | $72 → $25 | $7.50 | +233.56% | 3 | Mar 4, 2026 | |
| CLYM Climb Bio | Initiates: Overweight | $23 | $6.96 | +230.46% | 1 | Feb 13, 2026 | |
| KRRO Korro Bio | Upgrades: Overweight | $11 → $30 | $11.06 | +171.23% | 3 | Jan 29, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $450 → $1,200 | $310.54 | +286.42% | 4 | Jan 28, 2026 | |
| STTK Shattuck Labs | Initiates: Overweight | $15 | $6.19 | +142.33% | 1 | Jan 28, 2026 | |
| BIOA BioAge Labs | Initiates: Overweight | $73 | $17.65 | +313.60% | 1 | Jan 27, 2026 | |
| PALI Palisade Bio | Initiates: Overweight | $25 | $1.60 | +1,462.50% | 1 | Dec 29, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $540 → $900 | $522.83 | +72.14% | 5 | Dec 19, 2025 | |
| ORKA Oruka Therapeutics | Initiates: Overweight | $75 | $47.28 | +58.63% | 1 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $36 | $9.66 | +272.67% | 5 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $24.01 | +224.86% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $15.17 | +31.84% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $5.55 | +368.47% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $78 | $3.21 | +2,333.70% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $145 | $34.12 | +324.97% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 | $31.65 | +61.14% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.55 | +288.35% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $13.71 | +250.11% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $72.84 | +27.68% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $8.92 | +740.81% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $67.00 | +56.72% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $31.40 | +17.83% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $5.76 | +351.39% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $1.11 | +2,422.52% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $36.36 | +166.78% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $30.80 | +146.75% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $3.01 | +731.95% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $10.26 | +192.40% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $10.77 | +11.42% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.54 | +1,276.15% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.32 | +4,521.07% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $5.34 | +199.63% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $56.06 | +42.70% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $46.94 | +98.15% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $24.42 | +133.42% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $5.00 | +1,240.00% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $20 | $0.76 | +2,546.20% | 5 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $103.38 | -66.14% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $12.34 | +605.02% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $7.39 | +2,268.06% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $64.54 | +11.56% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.67 | +5,879.97% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $14.30 | +2,837.06% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $93.20 | -17.38% | 1 | Jul 31, 2020 |
Pliant Therapeutics
Mar 12, 2026
Maintains: Overweight
Price Target: $4 → $3
Current: $1.19
Upside: +152.10%
Arcturus Therapeutics Holdings
Mar 4, 2026
Maintains: Overweight
Price Target: $72 → $25
Current: $7.50
Upside: +233.56%
Climb Bio
Feb 13, 2026
Initiates: Overweight
Price Target: $23
Current: $6.96
Upside: +230.46%
Korro Bio
Jan 29, 2026
Upgrades: Overweight
Price Target: $11 → $30
Current: $11.06
Upside: +171.23%
Praxis Precision Medicines
Jan 28, 2026
Maintains: Overweight
Price Target: $450 → $1,200
Current: $310.54
Upside: +286.42%
Shattuck Labs
Jan 28, 2026
Initiates: Overweight
Price Target: $15
Current: $6.19
Upside: +142.33%
BioAge Labs
Jan 27, 2026
Initiates: Overweight
Price Target: $73
Current: $17.65
Upside: +313.60%
Palisade Bio
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $1.60
Upside: +1,462.50%
Madrigal Pharmaceuticals
Dec 19, 2025
Maintains: Overweight
Price Target: $540 → $900
Current: $522.83
Upside: +72.14%
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $47.28
Upside: +58.63%
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $9.66
Upside: +272.67%
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $24.01
Upside: +224.86%
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $15.17
Upside: +31.84%
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $5.55
Upside: +368.47%
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $3.21
Upside: +2,333.70%
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $34.12
Upside: +324.97%
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $31.65
Upside: +61.14%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.55
Upside: +288.35%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $13.71
Upside: +250.11%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $72.84
Upside: +27.68%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $8.92
Upside: +740.81%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $67.00
Upside: +56.72%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $31.40
Upside: +17.83%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $5.76
Upside: +351.39%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.11
Upside: +2,422.52%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $36.36
Upside: +166.78%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $30.80
Upside: +146.75%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $3.01
Upside: +731.95%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $10.26
Upside: +192.40%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $10.77
Upside: +11.42%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.54
Upside: +1,276.15%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.32
Upside: +4,521.07%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $5.34
Upside: +199.63%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $56.06
Upside: +42.70%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $46.94
Upside: +98.15%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $24.42
Upside: +133.42%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $5.00
Upside: +1,240.00%
Jul 21, 2023
Maintains: Overweight
Price Target: $13 → $20
Current: $0.76
Upside: +2,546.20%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $103.38
Upside: -66.14%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $12.34
Upside: +605.02%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $7.39
Upside: +2,268.06%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $64.54
Upside: +11.56%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.67
Upside: +5,879.97%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $14.30
Upside: +2,837.06%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $93.20
Upside: -17.38%